I Can See Health

   Chapter 857 Four-leaf petals! (First update!)

   After experiencing this new technique, Lu Chen also understood a little.

The TAVR skill card of the    system must surpass the expert level at the highest level!

The    expert level only includes the existing spells.

   But, with every operation, every period of time, there is an innovation.

   Lu Chen's eyes are no longer satisfied with mastering the current techniques, but to explore more techniques in depth to solve more intractable diseases.

   And the aortic stenosis patient from Huaxia successfully completed the TAVR operation in Lu Chen's hands.

   This time, Lu Chen was the chief surgeon, and Kenji Yamada was the first assistant.

   "Congratulations, the completion of the system upgrade has increased!"

   "Congratulations, thank you for receiving...!"

   The days in Mayo are very happy, the gratitude value and the system completion degree are increasing every day.

  …

   In the blink of an eye, it has been a year since Lu Chen came to Mayo.

   During this year.

  Lu Chen's name began to have a certain influence in the Mayo Cardiology Department.

   In the field of TAVR, Lu Chen's ability has been recognized by everyone.

   "Lu, there is an operation patient in our group, uh, I would like to invite you to the consultation."

   "Lu, tomorrow your group will accept a patient with severe refractory heart failure!"

   "Lu, there is a Global Cardiology TAVR Summit next week, and the hospital has decided to send you out to attend."

  Lu Chen had a good time at Mayo.

   There is not too much intrigue here, everyone is focused on clinical and scientific research.

   Everyone gets the same salary!

  No one has broken their heads and wants to be a management team.

  Lu Chen also has scientific research protection time, about 30% of the time per week, he can do his own research.

   Therefore, Lu Chen joined Kebed's scientific research team.

  This is not like Huaxia. As a Fellow Lu Chen, it is impossible to form his own scientific research team.

   "Lu, regarding the research and development of the latest TAVR technique, we have to improve the entire system." Kebed said to Lu Chen.

   As Lu Chen's abilities showed, Kebed paid more and more attention to Lu Chen.

   Even, he hardly manages clinical matters.

   All patients are under the unified management of Lu Chen.

   "Okay, Mr. Kebed."

  Lu Chen understands that Kebed wants to add this newly created spell to this year's TAVR guide.

   However, the rewriting of the guideline requires the support of evidence-based medicine.

   Just doing one or two operations can't explain any problems at all.

   At this time, Yamada Kenji suddenly walked into the office.

   "Mr. Kebed, there is an emergency consultation for a patient in the coronary artery group, and I would like to invite you to come."

  Kebed was stunned for a moment, then looked at Lu Chen, "Lu, let's go, I still have a lot of work to do in my lab."

   "Okay." Lu Chen nodded.

   Then, Kebed left.

In the    office, only Lu Chen and Yamada Kenji were left.

   "Lu Chenjun, Mr. Kebed's scientific research protection time is 50%. I think he wants to develop to 70% of the time, right?" Yamada Kenji raised his eyebrows.

   "As the attending doctor, Kebed has this power." Lu Chen smiled, "Mayo's management is still very humane, and clinical and scientific research can be taken into account, or one can be emphasized."

  Yamada Kenji spread his hands, "Mayo is Mayo, with such resources and conditions. Lu Chenjun, let's go, go to the coronary artery group to see, their patient seems to be quite troublesome."

"it is good."

  Lu Chen took his stethoscope and came to the coronary intervention group with Kenji Yamada.

  …

   Mayo's cardiology department is divided into many groups.

  Each group has a different focus. For example, the Kebed group is currently focusing on TAVR, and other groups include coronary intervention, electrophysiology, congenital heart disease, and so on.

  Lu Chen and Yamada Kenji came to the office of the coronary intervention group.

  Afro-American Fellow Salat is in his office looking at a patient's medical records.

   When he saw Lu Chen and Kenji Yamada coming in, he immediately stood up, "Lu, you've come!"

   As fellows from the same group, they now understand the gap between themselves and Lu Chen.

   "Where is the patient?" Lu Chen asked.

   "Where's the cath lab!" Salat said quickly, "I'll take you there now."

   "Catheter lab? Patients undergoing surgery?" Lu Chen was taken aback.

   "Yes!" Salat introduced while leading the way, "This operation was originally a coronary intervention, but the patient's aortic valve also had a problem. Our group of attending physicians decided to solve it together."

   This is in other hospitals, coronary intervention and TAVR intervention are absolutely impossible to do in one group.

   But at Mayo, there are many areas where each doctor excels.

   Even doctors in the coronary intervention group can perform most TAVR operations.

   "Then what is the patient's condition now? Why did you call us for a consultation during the operation?" Lu Chen asked in confusion.

   "It's just that the preoperative CT of the valve is different from what we found during the operation." Salat's expression was solemn, "Lu, you'll know when you go to the catheterization lab."

  …

   Mayo Cardiology Catheterization Lab.

   In operating room No. 3 at this time.

   The three surgeons were at a loss for the patient in front of them.

   "We were so unlucky that we encountered a four-leafed aortic valve!"

  As the first assistant of the operation, Casas couldn't help but complain,

   In the preoperative CT examination, this was not found.

   "It's useless to say these things now!" Lambert, the attending doctor in the group, frowned, "Quadleaf aortic valve, valve positioning is difficult, and we do it alone, and the success rate is too low!"

   The incidence of four-cuspid aortic valve (QAV) is extremely low. TAVR surgery for this type of patients has risks such as difficult valve positioning and coronary occlusion after valve implantation!

   "Did you call the doctor from the TAVR team here?"

   "A consultation has been requested, it should be on the way." Casas said.

   "Okay, let's stabilize the patient's vital signs first and wait for the doctor from the TAVR group to come."

   Two minutes later, Lu Chen came to the No. 3 catheterization room.

   "Lu, you are finally here!"

   Lambert was not surprised by Lu Chen's arrival.

   During the recent TAVR surgery consultation, Kebed basically didn't come, and Lu Chen did it for him.

   On the side, Casas said nothing.

   For Lu Chen, he was still a little unconvinced that the examination that Fellow reviewed was vivid in his mind.

   "What's the condition of the patient?" Lu Chen immediately began to read the patient's medical records.

   "We originally planned to do PCI+TAVR together." Lambert handed the patient's valve CT examination data to Lu Chen.

   "We originally expected that the valve disease was not serious, but now a four-leaf deformity has been found."

  Normal aortic valve, only three leaflets!

   And this patient has an extra leaf!

  Lu Chen stared at the patient's CT.

  CT showed a distributed quadrileaflet valve with small sinus, low coronary opening, and long and thick valve leaflets.

   The length of the left and right coronary leaflets exceeds the STJ height!

   "We just reassessed that during the valve implantation process, the risk of coronary occlusion is very high!" Lambert said, "So we invited you here."

  Lu Chen's expression was solemn.

   This patient's situation is too special.

   Not only coronary artery disease, but also aortic valve disease, and the two operations are performed at the same time, which is extremely demanding on the operator!

   (end of this chapter)